Skip to main content
Premium Trial:

Request an Annual Quote

Here's Lithuania

Lithuania is looking to become a new leader in biotech, reports Bernard Dichek at Nature's Trade Secrets blog, and the country is turning to Israel's biotech sector as a model. The country recently hosted a life sciences conference that drew about 800 attendees, including an Israeli delegation, he adds.

Dicheck notes, that like the Israeli industry a few years ago, Lithuania's "two main selling points seem to be 'good science + low costs.'" Science in Lithuania harkens back to when the Soviet Union established an enzymology institute there, and a few spinoff companies have been acquired by larger companies in recent years.

Additionally, Dichek writes that Lithuania also has a large number of expatriates, some of whom already work in biotech, who could return. "However in order for that trend to continue and for Lithuania to become a center of innovation, the country will have to succeed in attracting foreign investment," Dichek says. "The lack of a local venture capital community, stock exchange and other financial institutions that provide risk-oriented capital is a drawback to this."

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.